home / stock / gblx / gblx quote
Last: | $0.00671 |
---|---|
Change Percent: | 20.38% |
Open: | $0.005 |
Close: | $0.00671 |
High: | $0.0068 |
Low: | $0.005 |
Volume: | 81,311 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.00671 | $0.005 | $0.00671 | $0.0068 | $0.005 | 81,311 | 04-26-2024 |
$0.00628 | $0.0055 | $0.00628 | $0.0068 | $0.0055 | 19,739 | 04-25-2024 |
$0.00615 | $0.00659 | $0.00615 | $0.00659 | $0.005 | 95,102 | 04-24-2024 |
$0.0064 | $0.0064 | $0.0064 | $0.0074 | $0.00626 | 28,282 | 04-23-2024 |
$0.0065 | $0.0069 | $0.0065 | $0.0069 | $0.0065 | 35,150 | 04-22-2024 |
$0.00684 | $0.0065 | $0.00684 | $0.0069 | $0.0065 | 23,304 | 04-19-2024 |
$0.006445 | $0.0062 | $0.006445 | $0.006445 | $0.0062 | 20,951 | 04-18-2024 |
$0.0063 | $0.00655 | $0.0063 | $0.00655 | $0.0063 | 6,845 | 04-17-2024 |
$0.0062 | $0.0064 | $0.0062 | $0.00645 | $0.006 | 18,133 | 04-16-2024 |
$0.006525 | $0.00645 | $0.006525 | $0.006585 | $0.006 | 256,018 | 04-15-2024 |
$0.006315 | $0.0066 | $0.006315 | $0.0066 | $0.006 | 322,948 | 04-12-2024 |
$0.0065 | $0.00656 | $0.0065 | $0.0067 | $0.0065 | 75,935 | 04-11-2024 |
$0.0067 | $0.0065 | $0.0067 | $0.00684 | $0.0065 | 9,354 | 04-10-2024 |
$0.0065 | $0.0069 | $0.0065 | $0.0069 | $0.0065 | 136,616 | 04-09-2024 |
$0.0067 | $0.0065 | $0.0067 | $0.00678 | $0.0065 | 71,157 | 04-08-2024 |
$0.00665 | $0.00665 | $0.00665 | $0.0068 | $0.0065 | 50,100 | 04-05-2024 |
$0.00659 | $0.0066 | $0.00659 | $0.00672 | $0.00659 | 51,350 | 04-04-2024 |
$0.006735 | $0.00681 | $0.006735 | $0.0069 | $0.0067 | 112,105 | 04-03-2024 |
$0.0065 | $0.0063 | $0.0065 | $0.0069 | $0.0063 | 7,005 | 04-02-2024 |
$0.0065 | $0.0065 | $0.0065 | $0.0069 | $0.0061 | 108,513 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infect...
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which...
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selec...